Jason Brannen, MD
Orthopaedic Surgery · The Woodlands, TXNPI 1568610434
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,875 of the $18,290 with a category attached, or 64.9%. 21 manufacturers reported payments, led by Corin USA at 47.1% of the total. Reporting peaked in 2019 at $9,448 and has fallen 98.8% since, to $113 in 2025.
Across 45 payments — averaging $406.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corin USA$9K
- Intellijoint Surgical Inc.$8K
- Omnilife Science, Inc$734
- Stryker$426
- Johnson & Johnson$133
- Conformis, Inc.$86
- plus $356 from 15 others
What the payments were for
- Consulting fees$11,87565%
- Travel & lodging$3,98322%
- Food & beverage$2,41813%
- Entertainment$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corin USA | 7 | $8,617 |
| Intellijoint Surgical Inc. | 3 | $7,937 |
| Omnilife Science, Inc | 7 | $734 |
| Stryker | 6 | $426 |
| Johnson & Johnson | 4 | $133 |
| Conformis, Inc. | 1 | $86 |
| Davol Inc. | 2 | $42 |
| Boston Scientific | 1 | $41 |
| Naviswiss, Inc. | 1 | $32 |
| Biotronik NRO, Inc. | 1 | $32 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| Biosense Webster, Inc. | 1 | $28 |
| Abbott | 1 | $25 |
| BD | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Treace Medical Concepts, Inc. | 1 | $15 |
| Argentum Medical | 1 | $14 |
| Curonix LLC | 1 | $14 |
| Microport Orthopedics Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intellijoint HIP$7,877
- MAKO$313
How this compares
$18,290 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 172 | $1,798 |
| Diclofenac Sodium | 157 | $1,709 |
| Ibuprofen | 81 | $336 |
| Methylprednisolone | 28 | $227 |
| Tramadol Hcl | 25 | $136 |
| Cefadroxil | 24 | $56 |
| IbuIbuprofen | 14 | $51 |
| Amoxicillin | 32 | $23 |
| Clindamycin Hcl | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in The Woodlands
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Stefan KreuzerHouston$6.2M
- Michael WirthSan Antonio$4.5M
- Stephen IncavoHouston$4.3M
- Thomas EdwardsHouston$4.1M
- James BrodskyDallas$2.5M
- Robert SchmidtFort Worth$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.